Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort

Long-term clinical effectiveness of ustekinumab in patients with Crohn’s disease who failed biological therapies: a national cohort study

(2019) Claire Liefferinckx et al.   Journal of Crohns & Colitis

Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry

(2019) M. Iborra et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn’s Disease

(2019) Stephen B Hanauer et al.   Journal of Crohns & Colitis

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

(2019) Vince B C Biemans et al.   Journal of Crohns & Colitis

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

(2018) P. Wils et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Novel Targeted Therapies for Inflammatory Bowel Disease

(2017) Mehmet Coskun et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab

(2016) Kimberly A. Harris et al.   INFLAMMATORY BOWEL DISEASES

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD

(2015) Konstantinos Papamichael et al.   INFLAMMATORY BOWEL DISEASES

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

(2015) Michele W L Teng et al.   NATURE MEDICINE

Ustekinumab for the treatment of Crohn’s disease: can it find its niche?

(2015) Ebby G. Simon et al.   Therapeutic Advances in Gastroenterology

Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience

(2014) U. Kopylov et al.   Journal of Crohns & Colitis

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

“How to Manage Loss of Response to Anti-TNF in Crohns Disease?”

(2010) Walter Reinisch   CURRENT DRUG TARGETS